A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine
© Langley et al.; licensee BioMed Central Ltd. 2012
Received: 16 December 2011
Accepted: 11 October 2012
Published: 30 October 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|16 Dec 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|12 Jan 2012||Reviewed||Reviewer Report - Jiehui Kevin Yin|
|24 Jan 2012||Reviewed||Reviewer Report - Zol Vaj|
|30 Mar 2012||Author responded||Author comments - Joanne Langley|
|Resubmission - Version 3|
|30 Mar 2012||Submitted||Manuscript version 3|
|22 May 2012||Reviewed||Reviewer Report - Jiehui Kevin Yin|
|4 Jun 2012||Reviewed||Reviewer Report - Zol Vaj|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|Resubmission - Version 5|
|Submitted||Manuscript version 5|
|21 Aug 2012||Author responded||Author comments - Joanne Langley|
|Resubmission - Version 6|
|21 Aug 2012||Submitted||Manuscript version 6|
|15 Sep 2012||Reviewed||Reviewer Report - Zol Vaj|
|Resubmission - Version 7|
|Submitted||Manuscript version 7|
|11 Oct 2012||Editorially accepted|
|30 Oct 2012||Article published||10.1186/1471-2334-12-279|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.